S100A12 and Alzheimer disease: In alignment with the GEO data, our study demonstrated that mRNA expression of S100A12 in circulating peripheral white blood cells was elevated in patients with COSSH-ACLF compared to those with HC, CHB, AD, and APASL-ACLF.